Polydimethylsiloxane (PDMS) particles are a nonresorbable material that allows for permanent vocal fold augmentation. This study investigated morbidity and voice quality in patients treated for unilateral vocal fold paralysis by injection of PDMS particles.
Methods:
Fourteen patients who had neurogenic unilateral vocal fold paralysis of different causes were included in this prospective study. Each patient underwent videostroboscopic assessment before and after operation. Friedrich's dysphonia index (DI), a score system combining subjective and objective parameters, was used to describe voice quality. A DI of 0 reflects a normal voice, and a DI of 3 stands for complete aphonia. The PDMS particles were injected into the paraglottic space by microlaryngoscopy under general anesthesia.
Results:
The median follow-up was 4.1 months. There was no complication attributable to the injection of PDMS particles. The mean DI was 2.8 before operation. After the operation, voice quality improved significantly in each patient, as reflected by a mean postinjection DI of 1.4.
Conclusions:
Particles of PDMS provide a relatively safe and minimally invasive option for permanent vocal fold augmentation. The functional results in terms of voice improvement are comparable to those obtained with other techniques, including thyroplasty. In the European Community, PDMS particles are officially approved for use in the human larynx.
GuysJMSimeoni-AliasJFakhroADelarueA. Use of polydimethylsiloxane for endoscopic treatment of neurogenic urinary incontinence in children. J Urol1999; 162: 2133–5.
7.
HarrissDRIacovouJWLembergerRJ. Peri-urethral silicone microimplants (Macroplastique) for the treatment of genuine stress incontinence. Br J Urol1996; 78: 722–8.
8.
ColomboTAugustinHBreinlESchipsLHubmerG. The use of polydimethylsiloxane in the treatment of incontinence after radical prostatectomy. Br J Urol1997; 80: 923–6.
9.
HöflerHDumanM. Stimmlippenunterfütterung mit Bioplastique: Erste Ergebnisse. Zentralbl HNO1993: 577.
10.
GroffGDSchnedARTaylorTH. Silicone-induced adenopathy eight years after metacarpophalangeal arthroplasty. Arthritis Rheum1981; 24: 1578–81.
11.
CaballeroMBernal-SprekelsenMCalvoCFarreXQuintoLAlosL. Polydimethylsiloxane versus polytetrafluoroethylene for vocal fold medialization: Histologic evaluation in a rabbit model. J Biomed Mater Res B Appl Biomater2003; 67: 666–74.
12.
SittelC. Polydimethylsiloxane particles are not experimental in the human larynx. J Biomed Mater Res B Appl Biomater2004; 69: 251.
13.
MarottaJSWidenhouseCWHabalMBGoldbergEP. Silicone gel breast implant failure and frequency of additional surgeries: Analysis of 35 studies reporting examination of more than 8,000 explants. J Biomed Mater Res1999; 48: 354–64.
14.
GersztenKGersztenPC. Silicone breast implants: An oncologic perspective. Oncology (Huntingt)1998; 12: 1427–34, 1439–43.
15.
BrownSLLangoneJJBrintonLA. Silicone breast implants and autoimmune disease. J Am Med Womens Assoc1998; 53: 21–4, 40.
16.
RobinsonBVSullivanFMBorzellecaJFSchwartzSL. PVP: a critical review of the kinetics and toxicology of polyvinylpyrrolidone (povidone). Chelsea, Mich: Lewis Publishers, 1990.
17.
SittelCStennertEThumfartWFDapuntUEckelHE. Prognostic value of laryngeal electromyography in vocal fold paralysis. Arch Otolaryngol Head Neck Surg2001; 127: 155–60.
18.
FriedrichG. Titanium vocal fold medializing implant: Introducing a novel implant system for external vocal fold medialization. Ann Otol Rhinol Laryngol1999; 108: 79–86.
19.
FriedrichG. Qualitätssicherung in der Phoniatrie. Vorschlag zur Standardisierung der klinischen Stimmprüfung. HNO1996; 44: 401–16.
20.
DejonckerePHBradleyPClementeP.; Committee on Phoniatrics of the European Laryngological Society (ELS). A basic protocol for functional assessment of voice pathology, especially for investigating the efficacy of (phonosurgical) treatments and evaluating new assessment techniques. Guideline elaborated by the Committee on Phoniatrics of the European Laryngological Society (ELS). Eur Arch Otorhinolaryngol2001; 258: 77–82.
21.
D'AntonioLLWigleyTLZimmermanGJ. Quantitative measures of laryngeal function following Teflon injection or thyroplasty type I. Laryngoscope1995; 105: 256–62.
22.
DejonckerePH. Teflon injection and thyroplasty: Objective and subjective outcomes. Rev Laryngol Otol Rhinol (Bord)1998; 119: 265–9.
23.
HarriesMLMorrisonM. Management of unilateral vocal cord paralysis by injection medialization with Teflon paste. Quantitative results. Ann Otol Rhinol Laryngol1998; 107: 332–6.
24.
RubinHJ. Misadventures with injectable polytef (Teflon). Arch Otolaryngol1975; 101: 114–6.
25.
MaliziaAAJrReimanHMMyersRP. Migration and granulomatous reaction after periurethral injection of polytef (Teflon). JAMA1984; 251: 3277–81.
26.
VarvaresMAMontgomeryWWHillmanRE. Teflon granuloma of the larynx: Etiology, pathophysiology, and management. Ann Otol Rhinol Laryngol1995; 104: 511–5.
27.
FordCNBlessDM. A preliminary study of injectable collagen in human vocal fold augmentation. Otolaryngol Head Neck Surg1986; 94: 104–12.
28.
RemacleMMarbaixEHamoirMBertrandBvan den EeckhautJ. Correction of glottic insufficiency by collagen injection. Ann Otol Rhinol Laryngol1990; 99: 438–44.
29.
MikusJLKoufmanJAKilpatrickSE. Fate of liposuctioned and purified autologous fat injections in the canine vocal fold. Laryngoscope1995; 105: 17–22.
30.
ShawGYSzewczykMASearleJWoodroofJ. Autologous fat injection into the vocal folds: Technical considerations and long-term follow-up. Laryngoscope1997; 107: 177–86.
31.
McCullochTMAndrewsBTHoffmanHTGrahamSMKarnellMPMinnickC. Long-term follow-up of fat injection laryngoplasty for unilateral vocal cord paralysis. Laryngoscope2002; 112: 1235–8.
32.
RihkanenH. Vocal fold augmentation by injection of autologous fascia. Laryngoscope1998; 108: 51–4.
33.
ChanRWTitzeIR. Hyaluronic acid (with fibronectin) as a bioimplant for the vocal fold mucosa. Laryngoscope1999; 109: 1142–9.
34.
HallenLJohanssonCLaurentC. Cross-linked hyaluronan (Hylan B gel): A new injectable remedy for treatment of vocal fold insufficiency — An animal study. Acta Otolaryngol (Stockh)1999; 119: 107–11.
35.
KarpenkoANDworkinJPMelecaRJStachlerRJ. Cymetra injection for unilateral vocal fold paralysis. Ann Otol Rhinol Laryngol2003; 112: 927–34.
36.
ZapantaPEBielamowiczSA. Laryngeal abscess after injection laryngoplasty with micronized AlloDerm. Laryngoscope2004; 114: 1522–4.
37.
BelafskyPCPostmaGN. Vocal fold augmentation with calcium hydroxylapatite. Otolaryngol Head Neck Surg2004; 131: 351–4.
DuruisseauOWagnerIFugainCChabolleF. Endoscopic rehabilitation of vocal cord paralysis with a silicone elastomer suspension implant. Otolaryngol Head Neck Surg2004; 131: 241–7.
40.
SittelCThumfartWFPototschnigCWittekindtCEckelHE. Textured polydimethylsiloxane elastomers in the human larynx: Safety and efficiency of use. J Biomed Mater Res2000; 53: 646–50.
41.
BeisangAAIIIErsekRA. Mammalian response to subdermal implantation of textured microimplants. Aesthetic Plast Surg1992; 16: 83–90.
42.
AllenO. Response to subdermal implantation of textured microimplants in humans. Aesthetic Plast Surg1992; 16: 227–30.
43.
AlvesCBLoughranSMacGregorFBDeyJIBowieLJ. Bioplastique medialization therapy improves the quality of life in terminally ill patients with vocal cord palsy. Clin Otolaryngol Allied Sci2002; 27: 387–91.
